UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): June 13, 2011
Lifevantage Corporation
(Exact Name of Registrant as Specified in Charter)
|
|
|
|
|
Colorado
|
|
000-30489
|
|
90-0224471 |
(State or Other Jurisdiction
|
|
(Commission File Number)
|
|
(IRS Employer |
of Incorporation)
|
|
|
|
Identification No.) |
|
|
|
11545 W. Bernardo Court, Suite 301, San Diego, California
|
|
92127 |
(Address of Principal Executive Offices)
|
|
(Zip Code) |
Registrants Telephone Number, Including Area Code: (858) 312-8000
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b)) |
|
o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c)) |
Item 7.01. Regulation FD Disclosure.
Douglas C. Robinson, President and Chief Executive Officer of Lifevantage Corporation (the
Company), and Carrie McQueen, the Companys Chief Financial Officer, intend to present the
information attached hereto as Exhibit 99.1, in whole or in part, in one or more investor relations
discussions. A copy of the investor presentation is attached hereto as Exhibit 99.1 and is
incorporated herein by reference.
In accordance with General Instruction B.2 of Form 8-K, the foregoing information, including
Exhibit 99.1, shall not be deemed filed for the purposes of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that section, nor shall such information,
including Exhibit 99.1, be deemed incorporated by reference into any filing under the Securities
Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by
specific reference in such filing.
The information contained in the slides is summary information that is intended to be
considered in the context of Lifevantage Corporations filings with the Securities and Exchange
Commission (the SEC) and other public announcements that Lifevantage makes, by press release or
otherwise, from time to time. Lifevantage undertakes no duty or obligation to publicly update or
revise the information contained in this report, although it may do so from time to time as its
management believes is appropriate. Any such updating may be made through the filing of other
reports or documents with the SEC, through press releases or through other public disclosure.
Item 9.01. Financial Statements and Exhibits.
|
|
|
|
|
Exhibit No. |
|
Description |
|
99.1 |
|
|
Investor Presentation dated June 13, 2011 |
-2-